SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-003950
Filing Date
2020-02-10
Accepted
2020-02-10 07:25:10
Documents
15
Period of Report
2020-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agn-8k_20200210.htm   iXBRL 8-K 53268
2 EX-99.1 d72547ex991.htm EX-99.1 6293911
3 GRAPHIC allerganplclogo.jpg GRAPHIC 19031
  Complete submission text file 0001564590-20-003950.txt   6709438

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA agn-20200210.xsd EX-101.SCH 7898
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agn-20200210_def.xml EX-101.DEF 16137
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE agn-20200210_lab.xml EX-101.LAB 29506
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agn-20200210_pre.xml EX-101.PRE 17208
14 EXTRACTED XBRL INSTANCE DOCUMENT agn-8k_20200210_htm.xml XML 11335
Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36867 | Film No.: 20589313
SIC: 2834 Pharmaceutical Preparations